All attending UK organisations
UK companies attending as part of the official delegation
(Click here to search profiles):
UK Exhibitors
BioPartner UK: UK stand, booth 61a
Domainex: booth 61b
Cobra Biologics, Evaluate, Fujifilm Diosynth Biotechnologies, Informa Pharma intelligence, PR Newswire Europe
UK stand (booth 61abc) and Regional Groups:
Clinical Network Services (CNS), Chiltern Oncology, Datatrial, ERA Consulting UK, Fusion Antibodies, Illingworth Research, Manchester Science Partnerships, Medherant, PROVIDION, Sphere Fluidics, Sygnature Discovery, SYNthesis, UK Business Ambassador, United Life Sciences (BioPartner, BIA, One Nucleus, Mediwales)
Other UK companies associated with the delegation*:
Abcodia, Abel & Imray, Abzena, Alacrita, APCER Pharma, Aspire Pharma, BioAscent Discovery, BTG International, C4X Discovery Holdings, CIMYM BioSciences, CLINICAL ACCELERATOR, Crystec, Epidarex, EUSA Pharma, FranceMed Pharma, HC Pharma Consulting, Horizon Discovery, IDACO Consulting, Koi Consulting Partners, Kymab, Liftstream, MedPharm, Mewburn Ellis, Mundipharma International, Nanomerics, ProImmune, Propath/Fahy Gurteen, Quay Pharmaceuticals, ReViral, Scottish Devlopment International, Summit Therapeutics, Symbiosis Pharmaceutical Services, Theradex Europe, Therakind, Torreya Partners, UK Trade & Investment Sweden, University of Leicester- Research & Business Development Office, Upperton, Virttu Biologics, Worldwide Clinical Trials
UK Presenting companies:
C4X Discovery Holdings 9:00 Tuesday, Topivert Pharma 14:45 Tuesday
All attending UK companies:
3M United Kingdom, Abcodia, Abel & Imray, Abingworth, Abzena, Agalimmune, Alacrita, Albany Molecular Research Inc, Almac Discovery, AMCo, AMR Centre, Angiodesign (UK), Apcer Pharma, Apex Healthcare Consulting, Aptuit, Aspire Pharma, Astellas Pharma Europe, AstraZeneca, Atelix, Avanticell Science, Ayrton Saunders, Babraham Institute Enterprise, Barrington James, BBI Solutions, BioAscent Discovery, BioPartner UK, Biopharm Insight (Mergermarket & Editorial), Britannia Pharmaceuticals, BTG International, C4X Discovery Holdings, Cancer Research Technology, Chiltern Oncology, CIMYM BioSciences, Citigate Dewe Rogerson, CLINICAL ACCELERATOR, Clinical Network Services (CNS), Clinigen Group, Cmed Clinical Services, Cobra Biologics, Coulter Partners, Covance, Crescendo Biologics, Crystec, Datatrial, Domainex, Duke Street, Edison, Epidarex, ERA Consulting UK, Ergomed, EUSA Pharma, Evaluate, Ferghana Partners, FranceMed Pharma, F-star Biotechnology, Fujifilm Diosynth Biotechnologies, Fusion Antibodies, Galen, Georg Toufar, Gilead Sciences, GlaxoSmithKline, Glide Technologies, GlobalData, Haemostatix, HC Pharma Consulting, Horizon Discovery, Hypo-Stream, IDACO Consulting Limted, Illingworth Research, ImmuPharma, Immunocore, IMS, Informa, inVentiv Health, Invest in Denmark, J A Kemp, JGSbiopharma, Kaiser Associates, Koi Consulting Partners, Karus Therapeutics, KWS BioTest, Kymab, LGC, Life Sciences Hub Wales, Liftstream, Macrophage Pharma, Manchester Science Partnerships, Mawdsleys, Medherant, MedPharm, Mereo BioPharma Group, Merrill Corporation, Mewburn Ellis, Midatech, MISSION Therapeutics, Mitsubishi Tanabe Pharma, Monex Europe, Mundipharma International, Nanomerics, Napp Pharmaceuticals, Norgine, Norgine Ventures, OBN (UK), OCO Global, One Nucleus, ONO PHARMA UK, Oxford BioMedica, Oxford Genetics, PAREXEL International, Parkinson's UK, PCI Peptinnovate, Pharma Services, Pedersen & Partners, Pharma Intelligence | Informa, Pharma Publications, Pharmalicensing, Pharmaterials, PharmaVentures, Pharmorphix (Johnson Matthey Plc), PRA Health Sciences, Premier Research, ProImmune, Propath/Fahy Gurteen, PROVIDION, Psioxus Therapeutics, Pulmocide, Quay Pharmaceuticals, QuayPharmaceuticals, Quintiles, Randox Biosciences, ReViral, Rosetta Capital, Roslin Cell Therapies, Sage Healthcare, Saretius, Scottish Development International (SDI), Scrip Intelligence, Shield Therapeutics, SGS, Shin Poong Pharma, Shire Pharmaceutical, Silence Therapeutics, Sixth Element Capital LLP, Solid Form Solutions, Sphere Fluidics, Summit Therapeutics, Sygnature Discovery, Symbiosis Pharmaceutical Services, SYNthesis, SYNthesis, Teijin Pharma, Tepnel Pharma Services, The Fulford Group, The Institute of Cancer Research, Theradex Europe, Therakind, Thomson Reuters, Topivert Pharma, Torreya Partners, UK Business Ambassador, UK Trade & Investment, ULS (BioPartner, BIA, One Nucleus, Mediwales), Ulster University - Research & Innovation, Ulster University - School of Biomedical Sciences, University of Leicester- Research & Business Development Office, University of Manchester - Wellcome Trust Cente for Cell-Matrix Research, Faculty of Life Sciences, University of Oxford - Mathematical, Physical & Life Sciences Division, University of Southampton - Research and Innovation Services, University of Strathclyde - Pharmacy and Biomedical Science, Upperton, Vectura Group, Vernalis, VirdisGroup, Virttu Biologics, Visium Asset Management, Wellcome Trust Sanger Institute, WG Partners LLP, Wildwood Ventures, William Blair International, Worldwide Clinical Trials, Ziarco Pharma.
(179)
Join them here!
